Sesen Bio logo
Sesen Bio SESN

Quarterly report 2025-Q3
added 11-12-2025

report update icon

Sesen Bio Total Current Liabilities 2011-2026 | SESN

Annual Total Current Liabilities Sesen Bio

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
16.1 M 15.9 M 19.7 M 11.6 M 18 M 8.52 M 6.11 M 4.72 M 3.98 M 7.58 M 5.2 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
19.7 M 3.98 M 10.7 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
AbCellera Biologics AbCellera Biologics
ABCL
64.3 M $ 3.53 -0.98 % $ 1.05 B canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
5.75 M - 10.36 % $ 9.8 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
4.34 M $ 0.79 0.01 % $ 4.31 M chinaChina
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
36.4 M $ 6.59 -0.6 % $ 180 M israelIsrael
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
39.8 M $ 6.08 0.5 % $ 495 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
BioCardia BioCardia
BCDA
3.61 M $ 1.28 0.55 % $ 27.1 M usaUSA
Athersys Athersys
ATHX
29.9 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
31.1 M $ 14.49 0.91 % $ 212 M usaUSA
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
18.7 M - - $ 521 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
63.1 M $ 2.64 - $ 16.6 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
60.7 M $ 1.51 - $ 385 M britainBritain
Athira Pharma Athira Pharma
ATHA
13.1 M - - $ 269 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Actinium Pharmaceuticals Actinium Pharmaceuticals
ATNM
8.15 M $ 1.16 4.5 % $ 34.9 M usaUSA